These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 30324350)

  • 1. Applications of Nanoparticles Probes for Prostate Cancer Imaging and Therapy.
    Gao T; Bi A; Yang S; Liu Y; Kong X; Zeng W
    Adv Exp Med Biol; 2018; 1096():99-115. PubMed ID: 30324350
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nano-Theranostics for the Sensing, Imaging and Therapy of Prostate Cancers.
    Calatayud DG; Neophytou S; Nicodemou E; Giuffrida SG; Ge H; Pascu SI
    Front Chem; 2022; 10():830133. PubMed ID: 35494646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multifunctional nano-system for multi-mode targeted imaging and enhanced photothermal therapy of metastatic prostate cancer.
    Wang Z; Xing H; Liu A; Guan L; Li X; He L; Sun Y; Zvyagin AV; Yang B; Lin Q
    Acta Biomater; 2023 Aug; 166():581-592. PubMed ID: 37172637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An Overview on Applications of Gold Nanoparticle for Early Diagnosis and Targeted Drug Delivery to Prostate Cancer.
    Thambiraj S; Hema S; Shankaran DR
    Recent Pat Nanotechnol; 2018; 12(2):110-131. PubMed ID: 29090672
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanoformulations for Targeted Drug Delivery to Prostate Cancer: An Overview.
    Hema S; Thambiraj S; Shankaran DR
    J Nanosci Nanotechnol; 2018 Aug; 18(8):5171-5191. PubMed ID: 29458568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanoparticle therapeutics for prostate cancer treatment.
    Sanna V; Sechi M
    Nanomedicine; 2012 Sep; 8 Suppl 1():S31-6. PubMed ID: 22640911
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current progress of nanomedicine for prostate cancer diagnosis and treatment.
    Zhao J; Zhang C; Wang W; Li C; Mu X; Hu K
    Biomed Pharmacother; 2022 Nov; 155():113714. PubMed ID: 36150309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Update on Nanotechnology-based Drug Delivery Systems in Cancer Treatment.
    Ho BN; Pfeffer CM; Singh ATK
    Anticancer Res; 2017 Nov; 37(11):5975-5981. PubMed ID: 29061776
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanoparticles for Targeting of Prostate Cancer.
    Yari H; Gali H; Awasthi V
    Curr Pharm Des; 2020; 26(42):5393-5413. PubMed ID: 32693761
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostate Cancer Imaging and Therapy: Potential Role of Nanoparticles.
    Kilcoyne A; Harisinghani MG; Mahmood U
    J Nucl Med; 2016 Oct; 57(Suppl 3):105S-110S. PubMed ID: 27694162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current Perspectives on Novel Drug Delivery Systems and Therapies for Management of Prostate Cancer: An Inclusive Review.
    Bhosale RR; Gangadharappa HV; Hani U; Ali M Osmani R; Vaghela R; Kulkarni PK; Koganti VS
    Curr Drug Targets; 2017; 18(11):1233-1249. PubMed ID: 27296312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Jumping on the Bandwagon: A Review on the Versatile Applications of Gold Nanostructures in Prostate Cancer.
    Sarkis M; Ghanem E; Rahme K
    Int J Mol Sci; 2019 Feb; 20(4):. PubMed ID: 30813391
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of nanotechnology in prostate cancer theranostic applications.
    Cherian AM; Nair SV; Lakshmanan VK
    J Nanosci Nanotechnol; 2014 Jan; 14(1):841-52. PubMed ID: 24730302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular Imaging and Precision Medicine in Prostate Cancer.
    Ceci F; Fiorentino M; Castellucci P; Fanti S
    PET Clin; 2017 Jan; 12(1):83-92. PubMed ID: 27863569
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peptide-conjugated nanoparticles for targeted imaging and therapy of prostate cancer.
    Yeh CY; Hsiao JK; Wang YP; Lan CH; Wu HC
    Biomaterials; 2016 Aug; 99():1-15. PubMed ID: 27209258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nanoparticles Mediated Target-specific Drug Delivery in Prostate Cancer: An In-depth Review.
    Upadhyay TK; Ali MI; Khan F; Goel H; Mathur M; Goyal K; Moin S; Pandey P; Tanwar P; Sharangi AB; Gautam SDC; Kapdi JK; Patel KI; Patel MV; Parmar AM; Kamal MA
    Curr Med Chem; 2022; 29(24):4170-4184. PubMed ID: 34939536
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intraoperative assessment and postsurgical treatment of prostate cancer tumors using tumor-targeted nanoprobes.
    Teh J; Tripathi M; Reichel D; Sagong B; Montoya R; Zhang Y; Wagner S; Saouaf R; Chung LWK; Perez JM
    Nanotheranostics; 2021; 5(1):57-72. PubMed ID: 33391975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biomolecule-functionalized nanoformulations for prostate cancer theranostics.
    Pranav ; Laskar P; Jaggi M; Chauhan SC; Yallapu MM
    J Adv Res; 2023 Sep; 51():197-217. PubMed ID: 36368516
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advances in Urologic Imaging: Prostate-Specific Membrane Antigen Ligand PET Imaging.
    Hofman MS; Iravani A; Nzenza T; Murphy DG
    Urol Clin North Am; 2018 Aug; 45(3):503-524. PubMed ID: 30031469
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.